VirusBank Platform awarded a PAD grant by the Novo Nordisk Foundation

2 February 2026

We are honoured to announce that VirusBank Platform has been awarded a PAD grant by the Novo Nordisk Foundation, a significant milestone for our organisation and a meaningful recognition of the importance of building standardised, high-quality tools to accelerate the development of medical countermeasures for pandemic-threat viral pathogens.

Over the course of this three-year grant, VirusBank Platform will take a decisive step toward becoming an accredited, independent, non-profit European pandemic preparedness platform, while further strengthening and expanding our toolbox for viruses with epidemic and pandemic potential.

We sincerely thank the Novo Nordisk Foundation and Tina Thorslund for their trust in our team, KU Leuven, and our broader European partner network.

More information about the project and the award is available here: https://lnkd.in/eBAimG5u